BACE1 and Cognitive impairment: BACE1 is a key enzyme that initiates the formation of Aβ peptides, and studies have shown that the concentration and activity of BACE1 increase in patients with AD and Mild Cognitive Impairment (MCI) (Jankowsky et al., 2004; Zetterberg et al., 2008).